Physician profile
John C Patton
NPI 1194737346
$7,281.09
in general payments reported to CMS, 2019-2025
29 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $288 · 2021: $503 · 2022: $276 · 2023: $4,624 · 2024: $255 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $729 · Travel and Lodging: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $728.56 |
| Travel and Lodging | $311.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,462.59 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Stryker Corporation | $439.90 | 2020-2021 | |
| Smith+Nephew, INC. | $169.85 | 2023-2025 | Collagenase Santyl |
| Vertex Pharmaceuticals Incorporated | $132.36 | 2024-2025 | |
| Ethicon US, LLC | $114.52 | 2019-2021 | |
| Medtronic, INC. | $93.43 | 2021-2023 | Signia, Ligasure |
| Paratek Pharmaceuticals, INC. | $91.53 | 2022-2023 | Nuzyra |
| W. L. Gore & Associates, INC. | $82.32 | 2023-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Melinta Therapeutics, LLC | $82.02 | 2019 | |
| Conmed Corporation | $58.23 | 2019 | |
| Davol INC. | $58.13 | 2020-2022 | |
| Allergan, INC. | $56.95 | 2019 | |
| Covidien Lp | $55.72 | 2019-2020 | |
| Tela Bio, INC. | $54.91 | 2024 | Ovitex 2s |
| Kub Technologies INC. | $52.76 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $43.01 | 2024 | Novosorb Btm |
| Z-Medica, LLC | $31.68 | 2019-2020 | |
| Lsi Solutions INC | $26.40 | 2023 | Ti Knot |
| Electromed, INC. | $24.89 | 2019 | |
| Kerecis Limited | $20.15 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $18.46 | 2023 | Puraply |
| Hospira, INC. | $16.85 | 2023 | |
| Baxter Healthcare | $15.83 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.79 | 2025 | Exparel |
| Innocoll Pharmaceuticals Limited | $14.14 | 2022 | |
| Lilly USA, LLC | $13.07 | 2021 | |
| Thd America, INC. | $13.00 | 2021 | |
| Aesculap, INC. | $12.43 | 2019 | |
| Pfizer INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.